Shawn Tomasello

Shawn Tomasello joined the Centrexion Therapeutics board of directors in 2017. With over 30 years of experience in the pharmaceutical and biotech industries, Shawn currently serves as chief commercial officer of Kite Pharma. Prior to her role at Kite Pharma, Shawn served as chief commercial officer at Pharmacyclics, Inc., preceding its acquisition by AbbVie, Inc. She also held various senior leadership roles at Celgene Corporation, including president of the Americas, hematology and oncology. Earlier in her career, Shawn held positions at Genentech, Pfizer Laboratories, Miles Pharmaceuticals and Procter & Gamble. She currently serves on the board of Oxford BioTherapeutics and Diplomat Rx. Shawn received her B.S. in marketing from the University of Cincinnati and her MBA from Murray State University.